Ironwood Pharmaceuticals Inc
IRWD
Revenue
94.40M
▲19.52M▲26.07%
3 Months ChangeAssets
395.62M
▼-43.20M▼-9.84%
3 Months ChangeLiabilities
717.35M
▼-51.99M▼-6.76%
3 Months ChangeFree Cash Flow
44.92M
▼-35.24M▼-43.96%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-30
Form 8-K
ID: 0001104659-24-103925
2024-08-08
Form 10-Q
ID: 0001558370-24-011590
2024-08-08
Form 8-K
ID: 0001104659-24-086992
2024-06-21
Form 8-K
ID: 0001104659-24-073736
2024-06-20
Form 8-K
ID: 0001104659-24-073391
2024-05-09
Form 10-Q
ID: 0001558370-24-007640
2024-05-09
Form 8-K
ID: 0001104659-24-059101
2024-02-15
Form 8-K
ID: 0001104659-24-024345
2024-01-08
Form 8-K
ID: 0001104659-24-001989
2023-11-09
Form 10-Q
ID: 0001558370-23-018589